Cases 111 - 120 of 918
KAPLAN v. MYLAN N.V. et al
as 1:2021cv20159
Plaintiff:
WILLIAM KAPLAN
Defendant:
MYLAN N.V., MYLAN LABORATORIES LTD., MYLAN PHARMACEUTICALS INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332
CALLAHAN et al v. AUROBINDO PHARM, LTD. et al
as 1:2021cv20203
Plaintiff:
GAIL CALLAHAN and TIMOTHY CALLAHAN
Defendant:
AUROBINDO PHARM, LTD., MYLAN LABORATORIES, LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332
QUEZADA v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv00151
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
INSOKA QUEZADA
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., HUAHAI U.S. INC., PRINSTON PHARMACEUTICAL INC. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
JACKSON v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2022cv00154
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
KERRY JACKSON
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., HUAHAI U.S. INC., PRINSTON PHARMACEUTICAL INC. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
KRONEBERGER v. AUROBINDO PHARMA, LTD. et al
as 1:2021cv19938
Plaintiff:
LATRICIA KRONEBERGER
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES, LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
JANSSEN PHARMACEUTICALS, INC. et al v. MYLAN LABORATORIES LIMITED
as 3:2021cv15137
Plaintiff:
JANSSEN PHARMACEUTICALS, INC., JANSSEN PHARMACEUTICA NV and JANSSEN RESEARCH & DEVELOPMENT, LLC
Defendant:
MYLAN LABORATORIES LIMITED, MYLAN PHARMACEUTICALS INC. and MYLAN INSTITUTIONAL LLC
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
MASTBERGEN v. HETERO DRUGS, LTD. et al
as 1:2022cv00038
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
ESTATE OF NANCY MASTBERGEN
Defendant:
HETERO DRUGS, LTD., HETERO LABS, LTD., MYLAN LABORATORIES LTD. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
MCFARLAND v. MYLAN LABORATORIES LTD. et al
as 1:2021cv20783
Plaintiff:
AMANDA MCFARLAND
Defendant:
MYLAN LABORATORIES LTD., MYLAN N.V., MYLAN PHARMACEUTICALS INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
WORSHAM v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv00002
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
CATHERINE WORSHAM
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
BOURGES v. AUROBINDO PHARMA, LTD. et al
as 1:2021cv20769
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
ALVA BOURGES
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
